Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors ; volume:24 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer cell international ; 24, Heft 1 (10.9.2024), 1-13, 12.2024
- Urheber
-
Chen, Yi-Chao
Zheng, Wei-Zhong
Liu, Chun-Peng
Zhao, Yong-Qiang
Li, Jun-Wei
Du, Ze-Sen
Zhai, Tian-Tian
Lin, Hao-Yu
Shi, Wen-Qi
Cai, Shan-Qing
Pan, Feng
Qiu, Si-Qi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03496-x
- URN
-
urn:nbn:de:101:1-2411242123441.521066442970
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Yi-Chao
- Zheng, Wei-Zhong
- Liu, Chun-Peng
- Zhao, Yong-Qiang
- Li, Jun-Wei
- Du, Ze-Sen
- Zhai, Tian-Tian
- Lin, Hao-Yu
- Shi, Wen-Qi
- Cai, Shan-Qing
- Pan, Feng
- Qiu, Si-Qi
- SpringerLink (Online service)
Ähnliche Objekte (12)
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis of whole genomes
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis of whole genomes
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy
Human pan-cancer analysis of the predictive biomarker for the CDKN3
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis of whole genomes
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
A pan-cancer analysis of synonymous mutations